We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.

Durham Research Online
You are in:

Regulatory objectivity in action : mild cognitive impairment and the collective production of uncertainty.

Moreira, T. and May, C. and Bond, J. (2009) 'Regulatory objectivity in action : mild cognitive impairment and the collective production of uncertainty.', Social studies of science., 39 (5). pp. 665-690.


In this paper, we investigate recent changes in the definition and approach to Alzheimer’s disease brought about by growing clinical, therapeutic and regulatory interest in the prodromal or preclinical aspects of this condition. In the last decade, there has been an increased interest in the biomolecular and epidemiological characterization of pre-clinical dementia. It is argued that early diagnosis of dementia, and particularly of Alzheimer‘s disease, will facilitate the prevention of dementing processes and lower the prevalence of the condition in the general population. The search for a diagnostic category or biomarker that would serve this purpose is an ongoing but problematic endeavour for research and clinical communities in this area. In this paper, we explore how clinical and research actors, in collaboration with regulatory institutions and pharmaceutical companies, come to frame these domains as uncertainties and how they re-deploy uncertainty in the ‘collective production’ of new diagnostic conventions and bioclinical standards. While drawing as background on ethnographic, documentary and interview data, the paper proposes an in-depth, contextual analysis of the proceedings of an international meeting organized by the Peripheral and Central Nervous System Drug Advisory Committee of the US Food and Drug Administration to discuss whether or not a particular diagnostic convention — mild cognitive impairment — exists and how best it ought to be studied. Based on this analysis we argue that the deployment of uncertainty is reflexively implicated in bioclinical collectives’ search for rules and conventions, and furthermore that the collective production of uncertainty is central to the ‘knowledge machinery’ of regulatory objectivity.

Item Type:Article
Keywords:Alzheimer’s disease, Biomedicine, Diagnostic convention, Mild cognitive impairment, Uncertainty.
Full text:(AM) Accepted Manuscript
Download PDF
Publisher Web site:
Publisher statement:The final definitive version of this article has been published in the Journal Social studies of science 39/5 2009 © SAGE Publications Ltd at the Social studies of science page: on SAGE Journals Online:
Record Created:06 Jan 2010 12:20
Last Modified:06 Dec 2011 16:37

Social bookmarking: del.icio.usConnoteaBibSonomyCiteULikeFacebookTwitterExport: EndNote, Zotero | BibTex
Look up in GoogleScholar | Find in a UK Library